This is big news:
"Word came this morning that Biogen is dropping their anti-amyloid antibody (Aduhelm, aducanumab), so it's time to take stock. I was never happy about the FDA's decision to approve it, and that's putting it lightly."
https://www.science.org/content/blog-post/goodbye-aduhelm
@cyrilpedia Wow.
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.
@cyrilpedia
Wow.